Advisors Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Advisors Asset Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,091	Closed	-$58K	–	1915
2016 Q1	$58K	Buy	1,091 +26	+2%	+$1.92K	﹤0.01%	1593
2015 Q4	$120K	Sell	1,065 -2,641	-71%	-$291K	﹤0.01%	1508
2015 Q3	$436K	Buy	+3,706	New	+$484K	0.01%	1124

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Advisors Asset Management's ANAC Position: Q2 2016 in Review

Advisors Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 1,091 shares — an estimated $58K sold.

Advisors Asset Management first reported a position in ANAC in Q3 2015 and held it in 3 quarters. The position peaked at $436K in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Advisors Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Advisors Asset Management sold 1,091 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $58K.
Advisors Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2015 and held it in 3 quarters.
Advisors Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $436K in Q3 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Advisors Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.